Capture Oligonucleotide Density Control for Nucleic Acid Amplification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current nucleic acid amplification methods require multiple titration steps to achieve optimal cluster density on solid supports, which can lead to inefficiencies, reagent waste, and increased processing time, as cluster density is often dependent on the concentration of the nucleic acid sample.

Innovation Solution

A method involving immobilized oligonucleotides on a solid support, where capture oligonucleotides are used at a lower density than amplification oligonucleotides to selectively hybridize and control the density of nucleic acid clusters, allowing for independent control of cluster density regardless of the nucleic acid sample concentration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If multiple titration steps are used to achieve optimal cluster density, then cluster density can be optimized, but processing time increases and reagent waste occurs

Engineering Contradiction:
Improvecluster densityVSAvoidprocessing time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The solid support is pre-functionalized with a controlled density of oligonucleotide binding sites before sample application. This preliminary preparation establishes the maximum potential cluster density in advance, eliminating the need for time-consuming titration steps during the actual amplification process. The binding site density is controlled during solid support preparation, allowing direct achievement of optimal cluster density without iterative adjustments.

Inventive Principle:
Principle #10Preliminary action

2Manufacturing precision

If multiple titration steps are used to achieve optimal cluster density, then cluster density can be optimized, but reagent waste increases

Engineering Contradiction:
Improvecluster densityVSAvoidreagent waste
Core Design Contradiction:
Manufacturing precisionVSLoss of substance

Solution Approach 1:

The solid support is pre-functionalized with a controlled density of oligonucleotide binding sites before sample application. This preliminary preparation establishes the maximum potential cluster density in advance, eliminating the need for time-consuming titration steps during the actual amplification process. The binding site density is controlled during solid support preparation, allowing direct achievement of optimal cluster density without iterative adjustments.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If capture oligonucleotides are used at lower density than amplification oligonucleotides, then cluster density is controlled independently of sample concentration, but oligonucleotide immobilization complexity increases

Engineering Contradiction:
ImprovereproducibilityVSAvoidoligonucleotide immobilization
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The oligonucleotide population on the solid support is segmented into two distinct functional categories: capture oligonucleotides at lower density for selective hybridization and cluster density control, and amplification oligonucleotides at higher density for efficient signal generation. This segmentation allows independent optimization of each function and decouples cluster density from sample concentration dependencies.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Capture oligonucleotides serve as intermediary elements that mediate between the sample input and the amplification process. These intermediaries selectively bind target sequences and control the number of clusters formed, independent of the total sample concentration. The amplification oligonucleotides then act on these controlled clusters to generate detectable signals.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach reduces the need for sample titration, increases reproducibility, and optimizes cluster density, leading to more efficient and reliable nucleic acid amplification processes with reduced reagent usage and processing time.

Implementation Method 1

the template polynucleotides selectively hybridise to the capture oligonucleotides

Methodology Applied
Scientific EffectHybridization:

Data Source

PatentUS8999642B2Methods for selecting and amplifying polynucleotides
Publication Date: 2015.04.07 ILLUMINA INC
  • US8999642B2 patent drawing
  • US8999642B2 patent drawing
  • US8999642B2 patent drawing

AI summary

The invention provides methods for controlling the density of different molecular species on the surface of a solid support. A first mixture of different molecular species is attached to a solid support under conditions to attach each species at a desired density, thereby producing a derivatized support having attached capture molecules. The derivatized support is treated with a second mixture of different molecular species, wherein different molecular species in the second mixture bind specifically to the different capture molecules attached to the solid support. One or more of the capture molecules can be reversibly modified such that the capture molecules have a different activity before and after the second mixture of molecular species are attached. In particular embodiments, the different molecular species are nucleic acids that are reversibly modified to have different activity in an amplification reaction.